David B. Lovejoy

3.2k citations

25 papers · 2.9k indexed · h-index 18

Co-authors: Des R. Richardson Danuta S. Kalinowski Paul V. Bernhardt Philip C. Sharpe Jun Yuan Yu Yu Mohammad Shahidul Islam Patric J. Jansson
Topics: Metal complexes synthesis and properties (21 papers)Drug Transport and Resistance Mechanisms (11 papers)Trace Elements in Health (9 papers)
Cited by: Oncology Inorganic Chemistry Organic Chemistry
Journals: Blood Clinical Cancer Research Journal of Medicinal Chemistry
Partner nations: Australia United States United Kingdom

In The Last Decade

David B. Lovejoy

25 papers receiving 2.9k citations

Peers

Countries citing papers authored by David B. Lovejoy

Since Specialization

Citations

This map shows the geographic impact of David B. Lovejoy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David B. Lovejoy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David B. Lovejoy more than expected).

Fields of papers citing papers by David B. Lovejoy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David B. Lovejoy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David B. Lovejoy. The network helps show where David B. Lovejoy may publish in the future.

Co-authorship network of co-authors of David B. Lovejoy

This figure shows the co-authorship network connecting the top 25 collaborators of David B. Lovejoy. A scholar is included among the top collaborators of David B. Lovejoy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David B. Lovejoy. David B. Lovejoy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Anti-plasmodial activity of aroylhydrazone and thiosemicarbazone iron chelators: Effect on erythrocyte membrane integrity, parasite development and the intracellular labile iron pool 2013 ·Journal of Inorganic Biochemistry ·(unknown),Joseph Kurantsin‐Mills,John Kwagyan,(unknown),Danuta S. Kalinowski,David B. Lovejoy,Darius J.R. Lane,Des R. Richardson	30
2	The Iron Chelator, Deferasirox, as a Novel Strategy for Cancer Treatment: Oral Activity Against Human Lung Tumor Xenografts and Molecular Mechanism of Action 2012 ·Molecular Pharmacology ·Goldie Y.L. Lui,Peyman Obeidy,Samuel Ford,Chris Tselepis,Danae M. Sharp,Patric J. Jansson,Danuta S. Kalinowski,Žaklina Kovačević,David B. Lovejoy,Des R. Richardson	115
3	Development of a sensitive HPLC method to measure in vitro permeability of E- and Z-isomeric forms of thiosemicarbazones in Caco-2 monolayers 2012 ·Journal of Chromatography B ·Zufan Debebe,Sergeï Nekhai,(unknown),David B. Lovejoy,Danuta S. Kalinowski,Victor R. Gordeuk,(unknown),Des R. Richardson,Pradeep K. Karla	15
4	Novel Second-Generation Di-2-Pyridylketone Thiosemicarbazones Show Synergism with Standard Chemotherapeutics and Demonstrate Potent Activity against Lung Cancer Xenografts after Oral and Intravenous Administration in Vivo 2012 ·Journal of Medicinal Chemistry ·David B. Lovejoy,Danae M. Sharp,Nicole A. Seebacher,Peyman Obeidy,(unknown),Christian Stefani,Maram T. Basha,Philip C. Sharpe,Patric J. Jansson,Danuta S. Kalinowski,Paul V. Bernhardt,Des R. Richardson	179
5	The Medicinal Chemistry of Novel Iron Chelators for the Treatment of Cancer 2011 ·Current Topics in Medicinal Chemistry ·Žaklina Kovačević,Danuta S. Kalinowski,David B. Lovejoy,Yu Yu,Yohan Suryo Rahmanto,Philip C. Sharpe,Paul V. Bernhardt,Des R. Richardson	67
6	Membrane Transport and Intracellular Sequestration of Novel Thiosemicarbazone Chelators for the Treatment of Cancer 2010 ·Molecular Pharmacology ·Angelica M. Merlot,Namfon Pantarat,David B. Lovejoy,Danuta S. Kalinowski,Des R. Richardson	19
7	ChemInform Abstract: Thiosemicarbazones from the Old to New: Iron Chelators that Are More than Just Ribonucleotide Reductase Inhibitors 2009 ·ChemInform ·Yu Yu,Danuta S. Kalinowski,Žaklina Kovačević,A. Rosemary Siafakas,Patric J. Jansson,Christian Stefani,David B. Lovejoy,Philip C. Sharpe,Paul V. Bernhardt,Des R. Richardson	7
8	HPLC methods for determination of two novel thiosemicarbazone anti-cancer drugs (N4mT and Dp44mT) in plasma and their application to in vitro plasma stability of these agents 2008 ·Journal of Chromatography B ·(unknown),Petra Kovařı́ková,Jiřı́ Klimeš,David B. Lovejoy,Danuta S. Kalinowski,Des R. Richardson	18
9	Iron Chelators of the Dipyridylketone Thiosemicarbazone Class: Precomplexation and Transmetalation Effects on Anticancer Activity 2008 ·Journal of Medicinal Chemistry ·Paul V. Bernhardt,Philip C. Sharpe,Mohammad S. Islam,David B. Lovejoy,Danuta S. Kalinowski,Des R. Richardson	151
10	Design, Synthesis, and Characterization of Novel Iron Chelators: Structure−Activity Relationships of the 2-Benzoylpyridine Thiosemicarbazone Series and Their 3-Nitrobenzoyl Analogues as Potent Antitumor Agents 2007 ·Journal of Medicinal Chemistry ·Danuta S. Kalinowski,Yu Yu,Philip C. Sharpe,Mohammad Shahidul Islam,(unknown),David B. Lovejoy,Naresh Kumar,Paul V. Bernhardt,Des R. Richardson	205
11	Chelators at the Cancer Coalface: Desferrioxamine to Triapine and Beyond 2006 ·Clinical Cancer Research ·Yu Yu,Jacky Wong,David B. Lovejoy,Danuta S. Kalinowski,Des R. Richardson	170
12	Examination of the antiproliferative activity of iron chelators: multiple cellular targets and the different mechanism of action of triapine compared with desferrioxamine and the potent pyridoxal isonicotinoyl hydrazone analogue 311. 2003 ·PubMed ·Timothy B. Chaston,David B. Lovejoy,Ralph Watts,Des R. Richardson	179
13	Four cytotoxic N4-substituted thiosemicarbazones derived from 2-hydroxynaphthalene-1-carboxaldehyde 2003 ·Acta Crystallographica Section C Crystal Structure Communications ·Paul V. Bernhardt,(unknown),David B. Lovejoy,Des R. Richardson	9
14	Identification of the di‐pyridyl ketone isonicotinoyl hydrazone (PKIH) analogues as potent iron chelators and anti‐tumour agents 2003 ·British Journal of Pharmacology ·E. Becker,David B. Lovejoy,Judith M. Greer,Ralph Watts,Des R. Richardson	95
15	Novel aroylhydrazone and thiosemicarbazone iron chelators with anti-malarial activity against chloroquine-resistant and -sensitive parasites 2003 ·The International Journal of Biochemistry & Cell Biology ·(unknown),Mark Loyevsky,David B. Lovejoy,Victor R. Gordeuk,Des R. Richardson	187
16	Novel “hybrid” iron chelators derived from aroylhydrazones and thiosemicarbazones demonstrate selective antiproliferative activity against tumor cells 2002 ·Blood ·David B. Lovejoy,Des R. Richardson	155
17	Complexes of gallium(III) and other metal ions and their potential in the treatment of neoplasia 2000 ·Expert Opinion on Investigational Drugs ·David B. Lovejoy,Des R. Richardson	16
18	2-Hydroxy-1-naphthaldehyde 2-methylthiosemicarbazone 2000 ·Acta Crystallographica Section C Crystal Structure Communications ·David B. Lovejoy,Des R. Richardson,Paul V. Bernhardt	5
19	2-Hydroxy-1-naphthaldehyde 2-methylthiosemicarbazone 2000 ·Acta Crystallographica Section C Crystal Structure Communications ·David B. Lovejoy,Des R. Richardson,Paul V. Bernhardt	2
20	CHIRAL METAL COMPLEXES. PART 52. THE STRUCTURES OF CO-CRYSTALLISED DIASTEREOISOMERIC DNA PROBES SHOWING INTRAMOLECULAR π-π INTERACTIONS 1999 ·Journal of Coordination Chemistry ·David B. Lovejoy,Peter Leverett,Peter A. Williams,Robert S. Vagg	6

About David B. Lovejoy

David B. Lovejoy is a scholar working on Oncology, Inorganic Chemistry and Nutrition and Dietetics, having authored 25 papers that have together received 2.9k indexed citations. Recurring topics across this work include Metal complexes synthesis and properties (21 papers), Drug Transport and Resistance Mechanisms (11 papers) and Trace Elements in Health (9 papers). The work is most often cited by research in Oncology (1.7k citations), Inorganic Chemistry (524 citations) and Organic Chemistry (1.0k citations). David B. Lovejoy has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include Des R. Richardson, Danuta S. Kalinowski, Paul V. Bernhardt, Philip C. Sharpe, Jun Yuan, Yu Yu, Mohammad Shahidul Islam, Patric J. Jansson, Ralph Watts and Christian Stefani. Their work appears in journals such as Blood, Clinical Cancer Research and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact